Notes to the Company Financial Statements continued ii Directors and Employees Total emoluments of Directors including pension contributions amounted to 7.1 million 2017: 5.3 million.
Information relating to Directors emoluments, share options and pension entitlements is set out in the Directors Remuneration Report on pages 83 to 98.
Tony Griffins remuneration is paid by Dechra Veterinary Products EU in Euros but reported in Sterling for the purposes of these figures.
2018 2017 Number Number Administration 33 31 Total 33 31 The costs incurred in respect of these employees were: 2018 2017 m m Wages and salaries 4.5 4.3 Social security costs 0.7 0.6 Other pension costs 0.2 0.1 Share-based payments charge see note 28 3.3 2.8 Total 8.7 7.8 Related party transactions the remuneration of key management was as follows: 2018 2017 m m Short term employee benefits 4.4 3.6 Post-employment benefits 0.2 0.2 Share-based payments charge 1.5 1.4 6.1 5.2 Key management comprises the Board and the Senior Executive Team.
The Group operates a stakeholder personal pension scheme for certain employees and contributed between 4% and 14% of pensionable salaries.
Total pension contributions amounted to 0.2 million 2017: 0.1 million.
iii Profit loss Before Taxation The following items have been included in arriving at profit loss before taxation of continuing operations: 2018 2017 m m Depreciation of property, plant and equipment owned assets 0.1 0.1 Amortisation of intangible assets 0.9 0.6 Operating lease rentals payable 0.2 0.1 Auditors remuneration audit of these financial statements 0.1 0.1 iv Investments Shares in subsidiary undertakings m Cost At 1 July 2017 459.7 Additions 199.7 At 30 June 2018 659.4 Impairment At 1 July 2017 12.2 Charge for the period At 30 June 2018 12.2 Net book value At 30 June 2018 647.2 At 30 June 2017 447.5 A list of subsidiary undertakings is given in note xii.
During the year, the Company invested in Dechra Investments Limited and Dechra Finance Ireland DAC, both wholly owned subsidiaries.
160 Dechra Pharmaceuticals PLC Annual Report and Accounts for the year ended 30 June 2018 www.
